Literature DB >> 11774186

Reproducible gene expression measurement among multiple laboratories obtained in a blinded study using standardized RT (StaRT)-PCR.

E L Crawford1, G J Peters, P Noordhuis, M G Rots, M Vondracek, R C Grafström, K Lieuallen, G Lennon, R J Zahorchak, M J Georgeson, A Wali, J F Lechner, P S Fan, M B Kahaleh, S A Khuder, K A Warner, D A Weaver, J C Willey.   

Abstract

BACKGROUND: A method that provides standardized data and is relatively inexpensive and capable of high throughput is a prerequisite to the development of a meaningful gene expression database suitable for conducting multi-institutional clinical studies based on expression measurement. Standardized RT (StaRT)-PCR has all these characteristics. In addition, the method must be reproducible. StaRT-PCR has high intralaboratory reproducibility. The purpose of this study is to determine whether StaRT-PCR provides similar interlaboratory reproducibility. METHODS AND
RESULTS: In a blinded interlaboratory study, expression of ten genes was measured by StaRT-PCR in a complementary DNA sample provided to each of four laboratories. The average coefficient of variation for interlaboratory comparison of the nine quantifiable genes was 0.48. In all laboratories, expression of one of the genes was too low to be measured.
CONCLUSION: Because StaRT-PCR data are standardized and numerical and the method is reproducible among multiple laboratories, it will allow development of a meaningful gene expression database.

Mesh:

Substances:

Year:  2001        PMID: 11774186     DOI: 10.1007/bf03262057

Source DB:  PubMed          Journal:  Mol Diagn        ISSN: 1084-8592


  11 in total

1.  Do-it-yourself gene watching.

Authors:  E Marshall
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

2.  Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients.

Authors:  S Mollerup; D Ryberg; A Hewer; D H Phillips; A Haugen
Journal:  Cancer Res       Date:  1999-07-15       Impact factor: 12.701

3.  Normal bronchial epithelial cell expression of glutathione transferase P1, glutathione transferase M3, and glutathione peroxidase is low in subjects with bronchogenic carcinoma.

Authors:  E L Crawford; S A Khuder; S J Durham; M Frampton; M Utell; W G Thilly; D A Weaver; W J Ferencak; C A Jennings; J R Hammersley; D A Olson; J C Willey
Journal:  Cancer Res       Date:  2000-03-15       Impact factor: 12.701

4.  Reverse transcription-competitive multiplex PCR improves quantification of mRNA in clinical samples--application to the low abundance CFTR mRNA.

Authors:  S M Loitsch; S Kippenberger; N Dauletbaev; T O Wagner; J Bargon
Journal:  Clin Chem       Date:  1999-05       Impact factor: 8.327

5.  Enhanced insulin-like growth factor binding protein-related protein 2 (Connective tissue growth factor) expression in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis.

Authors:  J T Allen; R A Knight; C A Bloor; M A Spiteri
Journal:  Am J Respir Cell Mol Biol       Date:  1999-12       Impact factor: 6.914

6.  A rapid and versatile method to synthesize internal standards for competitive PCR.

Authors:  F S Celi; M E Zenilman; A R Shuldiner
Journal:  Nucleic Acids Res       Date:  1993-02-25       Impact factor: 16.971

7.  Circumvention of methotrexate resistance in childhood leukemia subtypes by rationally designed antifolates.

Authors:  M G Rots; R Pieters; G J Peters; C H van Zantwijk; R Mauritz; P Noordhuis; J C Willey; K Hählen; U Creutzig; G Janka-Schaub; G J Kaspers; A J Veerman; G Jansen
Journal:  Blood       Date:  1999-11-01       Impact factor: 22.113

8.  mRNA expression levels of methotrexate resistance-related proteins in childhood leukemia as determined by a standardized competitive template-based RT-PCR method.

Authors:  M G Rots; J C Willey; G Jansen; C H Van Zantwijk; P Noordhuis; J P DeMuth; E Kuiper; A J Veerman; R Pieters; G J Peters
Journal:  Leukemia       Date:  2000-12       Impact factor: 11.528

9.  Expression measurement of many genes simultaneously by quantitative RT-PCR using standardized mixtures of competitive templates.

Authors:  J C Willey; E L Crawford; C M Jackson; D A Weaver; J C Hoban; S A Khuder; J P DeMuth
Journal:  Am J Respir Cell Mol Biol       Date:  1998-07       Impact factor: 6.914

10.  The gene expression index c-myc x E2F-1/p21 is highly predictive of malignant phenotype in human bronchial epithelial cells.

Authors:  J P DeMuth; C M Jackson; D A Weaver; E L Crawford; D S Durzinsky; S J Durham; A Zaher; E R Phillips; S A Khuder; J C Willey
Journal:  Am J Respir Cell Mol Biol       Date:  1998-07       Impact factor: 6.914

View more
  9 in total

1.  The c-myc x E2F-1/p21 interactive gene expression index augments cytomorphologic diagnosis of lung cancer in fine-needle aspirate specimens.

Authors:  Kristy A Warner; Erin L Crawford; Aiman Zaher; Robert J Coombs; Haitham Elsamaloty; Stacie L Roshong-Denk; Imran Sharief; Guillermo V Amurao; Yongsook Yoon; Amro Y Al-Astal; Ragheb A Assaly; Dawn-Alita R Hernandez; Timothy G Graves; Charles R Knight; Michael W Harr; Todd B Sheridan; Jeffrey P DeMuth; Robert J Zahorchak; Jeffrey R Hammersley; Dan E Olson; Samuel J Durham; James C Willey
Journal:  J Mol Diagn       Date:  2003-08       Impact factor: 5.568

2.  The use of genetic programming in the analysis of quantitative gene expression profiles for identification of nodal status in bladder cancer.

Authors:  Anirban P Mitra; Arpit A Almal; Ben George; David W Fry; Peter F Lenehan; Vincenzo Pagliarulo; Richard J Cote; Ram H Datar; William P Worzel
Journal:  BMC Cancer       Date:  2006-06-16       Impact factor: 4.430

3.  Variation in transcriptional regulation of cyclin dependent kinase inhibitor p21waf1/cip1 among human bronchogenic carcinomas.

Authors:  Michael W Harr; Timothy G Graves; Erin L Crawford; Kristy A Warner; Cheryl A M Reed; James C Willey
Journal:  Mol Cancer       Date:  2005-07-13       Impact factor: 27.401

4.  ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines.

Authors:  David A Weaver; Erin L Crawford; Kristy A Warner; Fadel Elkhairi; Sadik A Khuder; James C Willey
Journal:  Mol Cancer       Date:  2005-05-09       Impact factor: 27.401

5.  RNAseq analysis of bronchial epithelial cells to identify COPD-associated genes and SNPs.

Authors:  Jiyoun Yeo; Diego A Morales; Tian Chen; Erin L Crawford; Xiaolu Zhang; Thomas M Blomquist; Albert M Levin; Pierre P Massion; Douglas A Arenberg; David E Midthun; Peter J Mazzone; Steven D Nathan; Ronald J Wainz; Patrick Nana-Sinkam; Paige F S Willey; Taylor J Arend; Karanbir Padda; Shuhao Qiu; Alexei Federov; Dawn-Alita R Hernandez; Jeffrey R Hammersley; Youngsook Yoon; Fadi Safi; Sadik A Khuder; James C Willey
Journal:  BMC Pulm Med       Date:  2018-03-05       Impact factor: 3.317

6.  External oligonucleotide standards enable cross laboratory comparison and exchange of real-time quantitative PCR data.

Authors:  Joëlle Vermeulen; Filip Pattyn; Katleen De Preter; Liesbeth Vercruysse; Stefaan Derveaux; Pieter Mestdagh; Steve Lefever; Jan Hellemans; Frank Speleman; Jo Vandesompele
Journal:  Nucleic Acids Res       Date:  2009-11       Impact factor: 16.971

7.  Sensitivity and reproducibility of standardized-competitive RT-PCR for transcript quantification and its comparison with real time RT-PCR.

Authors:  Vincenzo Pagliarulo; Ben George; Stephen J Beil; Susan Groshen; Peter W Laird; Jie Cai; James Willey; Richard J Cote; Ram H Datar
Journal:  Mol Cancer       Date:  2004-01-23       Impact factor: 27.401

8.  Targeted RNA-sequencing with competitive multiplex-PCR amplicon libraries.

Authors:  Thomas M Blomquist; Erin L Crawford; Jennie L Lovett; Jiyoun Yeo; Lauren M Stanoszek; Albert Levin; Jia Li; Mei Lu; Leming Shi; Kenneth Muldrew; James C Willey
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

9.  Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity.

Authors:  M de Bruin; T van Capel; K Van der Born; F A Kruyt; M Fukushima; K Hoekman; H M Pinedo; G J Peters
Journal:  Br J Cancer       Date:  2003-03-24       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.